Cargando…

Polypharmacy in the Homebound Population

The number of homebound elders has risen dramatically in the past decade and was accelerated by the Sars-Cov-2 COVID-19 pandemic. These individuals generally have 5 or more chronic conditions, take 6 or more medications, and are at elevated risk for functional decline. Polypharmacy constitutes a maj...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Erin Atkinson, Duenas, Maria, Harris, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468911/
https://www.ncbi.nlm.nih.gov/pubmed/36210084
http://dx.doi.org/10.1016/j.cger.2022.05.008
_version_ 1784788524615073792
author Cook, Erin Atkinson
Duenas, Maria
Harris, Patricia
author_facet Cook, Erin Atkinson
Duenas, Maria
Harris, Patricia
author_sort Cook, Erin Atkinson
collection PubMed
description The number of homebound elders has risen dramatically in the past decade and was accelerated by the Sars-Cov-2 COVID-19 pandemic. These individuals generally have 5 or more chronic conditions, take 6 or more medications, and are at elevated risk for functional decline. Polypharmacy constitutes a major burden for these individuals, putting them at risk for medication nonadherence, medication errors, medication interactions, and reduced quality of life. A team-based approach may help these elders manage medications more effectively.
format Online
Article
Text
id pubmed-9468911
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-94689112022-09-13 Polypharmacy in the Homebound Population Cook, Erin Atkinson Duenas, Maria Harris, Patricia Clin Geriatr Med Article The number of homebound elders has risen dramatically in the past decade and was accelerated by the Sars-Cov-2 COVID-19 pandemic. These individuals generally have 5 or more chronic conditions, take 6 or more medications, and are at elevated risk for functional decline. Polypharmacy constitutes a major burden for these individuals, putting them at risk for medication nonadherence, medication errors, medication interactions, and reduced quality of life. A team-based approach may help these elders manage medications more effectively. Elsevier Inc. 2022-11 2022-09-13 /pmc/articles/PMC9468911/ /pubmed/36210084 http://dx.doi.org/10.1016/j.cger.2022.05.008 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Cook, Erin Atkinson
Duenas, Maria
Harris, Patricia
Polypharmacy in the Homebound Population
title Polypharmacy in the Homebound Population
title_full Polypharmacy in the Homebound Population
title_fullStr Polypharmacy in the Homebound Population
title_full_unstemmed Polypharmacy in the Homebound Population
title_short Polypharmacy in the Homebound Population
title_sort polypharmacy in the homebound population
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468911/
https://www.ncbi.nlm.nih.gov/pubmed/36210084
http://dx.doi.org/10.1016/j.cger.2022.05.008
work_keys_str_mv AT cookerinatkinson polypharmacyinthehomeboundpopulation
AT duenasmaria polypharmacyinthehomeboundpopulation
AT harrispatricia polypharmacyinthehomeboundpopulation